kth.sePublications KTH
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Machine learning identifies proteomic risk factors across 23 diseases
KTH, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Protein Science, Systems Biology. KTH, Centres, Science for Life Laboratory, SciLifeLab.ORCID iD: 0000-0001-9986-9205
KTH, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Protein Science, Systems Biology. KTH, Centres, Science for Life Laboratory, SciLifeLab.ORCID iD: 0009-0008-6359-5714
KTH, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Protein Science, Systems Biology. KTH, Centres, Science for Life Laboratory, SciLifeLab.
KTH, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH). KTH, Centres, Science for Life Laboratory, SciLifeLab.
Show others and affiliations
2026 (English)In: iScience, E-ISSN 2589-0042, Vol. 29, no 2, article id 114687Article in journal (Refereed) Published
Abstract [en]

Achieving minimally invasive and rapid detection is a crucial goal in modern medicine. The comprehensive characterization of the blood proteome holds great promise in advancing our understanding of disease etiology, facilitating early diagnosis, risk stratification, and improved monitoring across various diseases and their subtypes. In this study, we collected plasma proteomes from over 3000 patients, representing 23 distinct diseases, encompassing a total of 1462 proteins. Based on histological knowledge, we developed a two-stage hierarchical multi-disease classifier and applied it to perform multi-disease classification on the collected proteomic data. Our results demonstrate that this empirically guided two-stage hierarchical multi-disease classifier outperforms traditional machine learning algorithms in terms of prediction performance, showing better balance and more meaningful feature selections. This finding highlights the positive role that domain expertise can play in machine learning-based disease detection, and underscores the potential of plasma proteomics for multi-disease screening.

Place, publisher, year, edition, pages
Elsevier BV , 2026. Vol. 29, no 2, article id 114687
Keywords [en]
machine learning, medicine, proteomics
National Category
Basic Medicine
Identifiers
URN: urn:nbn:se:kth:diva-377158DOI: 10.1016/j.isci.2026.114687ISI: 001679587600001PubMedID: 41660256Scopus ID: 2-s2.0-105028660136OAI: oai:DiVA.org:kth-377158DiVA, id: diva2:2041628
Note

QC 20260225

Available from: 2026-02-25 Created: 2026-02-25 Last updated: 2026-02-25Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Meng, LingqiLi, MengzhenKong, XiangtaiZhang, TonghuaBueno Alvez, MariaLiao, XinmengAltay, OzlemZhang, ChengUhlén, MathiasMardinoglu, Adil

Search in DiVA

By author/editor
Meng, LingqiLi, MengzhenKong, XiangtaiZhang, TonghuaBueno Alvez, MariaLiao, XinmengAltay, OzlemZhang, ChengUhlén, MathiasMardinoglu, Adil
By organisation
Systems BiologyScience for Life Laboratory, SciLifeLabSchool of Engineering Sciences in Chemistry, Biotechnology and Health (CBH)
In the same journal
iScience
Basic Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 33 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf